Literature DB >> 10681411

Phospholipid transfer protein gene knock-out mice have low high density lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV-rich lamellar lipoproteins.

S Qin1, K Kawano, C Bruce, M Lin, C Bisgaier, A R Tall, X Jiang.   

Abstract

Phospholipid transfer protein gene knock-out (Pltp KO) mice have defective transfer of very low density lipoprotein (VLDL) phospholipids into high density lipoprotein (HDL) and markedly decreased HDL levels (Jiang et al. 1999. J. Clin. Invest. 103: 907-914). These animals also accumulated VLDL- and LDL-sized lipoproteins on a high saturated fat diet. The goals of this study were to further characterize the abnormal lipoproteins of Pltp KO mice and to determine the mechanisms responsible for low HDL levels. A lipoprotein fraction enriched in lamellar structures was isolated from the low density lipoprotein (LDL) region and was shown to be phospholipid- and free cholesterol-rich and to have apoA-IV (55%) and apoE (25%) as major apolipoproteins. The lamellar lipoproteins accumulating in these mice probably represent surface material derived from triglyceride-rich lipoproteins (TRL). The HDL was found to be protein-rich (primarily apoA-I) and specifically depleted in phosphatidylcholine (PC) (28% in wild-type mice (WT) vs. 15% in Pltp KO mice, P < 0.001). Unexpectedly, turnover studies using autologous HDL revealed a profound 4-fold increase in the catabolism of HDL protein and cholesteryl ester in Pltp KO mice compared to wild-type, with minor differences in synthesis rates. In contrast, injection of WT mouse HDL into Pltp KO mice showed only a 2-fold increase in fractional catabolism. Reminiscent of the defect in Tangier disease, the failure of transfer of PC from TRL into the HDL fraction results in dramatic hypercatabolism of HDL. These results suggest that defective phospholipid transfer from TRL into HDL, arising from decreased lipolysis or decreased PLTP activity, could lead to hypoalphalipoproteinemia characterized by hypercatabolism of HDL protein. lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV-rich lamellar lipoproteins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10681411

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  24 in total

1.  Liver phospholipid transfer protein (PLTP) expression with a PLTP-null background promotes very low-density lipoprotein production in mice.

Authors:  Amirfarbod Yazdanyar; Xian-Cheng Jiang
Journal:  Hepatology       Date:  2012-06-11       Impact factor: 17.425

Review 2.  Genetic determinants of cardiometabolic risk: a proposed model for phenotype association and interaction.

Authors:  Piers R Blackett; Dharambir K Sanghera
Journal:  J Clin Lipidol       Date:  2012-04-22       Impact factor: 4.766

Review 3.  Impact of Phospholipid Transfer Protein in Lipid Metabolism and Cardiovascular Diseases.

Authors:  Xian-Cheng Jiang
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 4.  Phospholipid transfer protein: its impact on lipoprotein homeostasis and atherosclerosis.

Authors:  Xian-Cheng Jiang
Journal:  J Lipid Res       Date:  2018-02-08       Impact factor: 5.922

5.  Diet-induced lipid accumulation in phospholipid transfer protein-deficient mice: its atherogenicity and potential mechanism.

Authors:  Calvin Yeang; Shucun Qin; Kailian Chen; David Q-H Wang; Xian-Cheng Jiang
Journal:  J Lipid Res       Date:  2010-06-11       Impact factor: 5.922

6.  Ezetimibe inhibits hepatic Niemann-Pick C1-Like 1 to facilitate macrophage reverse cholesterol transport in mice.

Authors:  Ping Xie; Lin Jia; Yinyan Ma; Juanjuan Ou; Hongming Miao; Nanping Wang; Feng Guo; Amirfarbod Yazdanyar; Xian-Cheng Jiang; Liqing Yu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-03-07       Impact factor: 8.311

7.  PLTP is present in the nucleus, and its nuclear export is CRM1-dependent.

Authors:  Simona Vuletic; Weijiang Dong; Gertrud Wolfbauer; Joseph R Day; John J Albers
Journal:  Biochim Biophys Acta       Date:  2009-01-24

Review 8.  The role of sphingosine-1-phosphate in endothelial barrier function.

Authors:  Brent A Wilkerson; Kelley M Argraves
Journal:  Biochim Biophys Acta       Date:  2014-07-05

9.  Plasma PLTP activity is inversely associated with HDL-C levels.

Authors:  Xueying Chen; Aijun Sun; Ather Mansoor; Yunzeng Zou; Junbo Ge; Jason M Lazar; Xian-Cheng Jiang
Journal:  Nutr Metab (Lond)       Date:  2009-11-30       Impact factor: 4.169

Review 10.  Lipoproteins, cholesterol homeostasis and cardiac health.

Authors:  Tyler F Daniels; Karen M Killinger; Jennifer J Michal; Raymond W Wright; Zhihua Jiang
Journal:  Int J Biol Sci       Date:  2009-06-29       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.